InsiderTrades

Form 4 for OABI OmniAb, Inc.

Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0000899243-22-035062 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-11-03 2022-11-01 OABI Boyce Sarah Dir A - Grant — +37.4K 37.4K New —
DM 2022-11-03 2022-11-01 OABI Boyce Sarah Dir A - Grant — +85.0K 37.8K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-01 A A 37,437 — 37,437 D — — (F3) Includes 14,512 earn-out shares subject to forfeiture provisions described in the Merger Agreement. (F2) Includes 8,753 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire. (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.
2 Derivative Stock Option 2022-11-01 A A 22,616 — 22,616 D $12.37 · — to 2029-10-15 22,616 Common Stock (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable.
3 Derivative Stock Option 2022-11-01 A A 10,565 — 10,565 D $13.49 · — to 2030-06-10 10,565 Common Stock (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable.
4 Derivative Stock Option 2022-11-01 A A 13,994 — 13,994 D $13.24 · — to 2031-06-04 13,994 Common Stock (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable.
5 Derivative Stock Option 2022-11-01 A A 37,840 — 37,840 D $9.10 · — to 2032-06-10 37,840 Common Stock (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F5) The stock option fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on June 10, 2023.